| PACB Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the PACB shares outstanding history going back to 10/27/2010:
Also see: PACB Market Cap History PACB YTD Return |
As of 4/30/2026 Pacific Biosciences of California has 310.60 million PACB shares outstanding. Investors often track the PACB shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows PACB share count trends over time, with 63 historical shares outstanding datapoints presented, dating back to 10/27/2010.

| PACB Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the PACB shares outstanding history going back to 10/27/2010:
Also see: PACB Market Cap History PACB YTD Return |
| PACB Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PACB Historical Shares Outstanding: +12.47% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PACB Stock Price Chart |
| About Pacific Biosciences of California Inc |
| Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. We show 63 historical shares outstanding datapoints in our coverage of PACB's shares outstanding history. Understanding the changing numbers of PACB shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PACB versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PACB by allowing them to research PACB shares outstanding history as well as any other stock in our coverage universe. |
| PACB Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| PACB Share Performance |
| Shares Outstanding Peers |
| Pacific Biosciences of California (PACB) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
PACS Shares Outstanding History PAHC Shares Outstanding History PALI Shares Outstanding History PAND Shares Outstanding History PASG Shares Outstanding History PAVM Shares Outstanding History PBH Shares Outstanding History PBLA Shares Outstanding History PBYI Shares Outstanding History PCRX Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.